Cosmo Pharmaceuticals N.V. (LON:0RGI)

Cosmo Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	836	901	763	900	895	1,018
Market Cap Growth	18.10%	18.10%	-15.23%	0.57%	-12.08%	16.39%
Enterprise Value	721	795	727	864	864	956
Last Close Price	52.22	54.21	44.95	50.96	47.90	63.34
PE Ratio	7.59	8.18	-	58.91	49.16	-
PS Ratio	3.79	4.08	9.48	9.94	16.37	18.64
PB Ratio	2.00	2.16	2.18	2.19	2.08	2.84
P/TBV Ratio	3.23	3.48	3.43	14.09	9.52	2.87
P/FCF Ratio	6.41	6.90	45.41	35.34	149.55	128.14
P/OCF Ratio	6.23	6.71	38.72	30.54	84.48	87.48
EV/Sales Ratio	3.14	3.60	9.03	9.54	15.80	17.50
EV/EBITDA Ratio	5.20	5.99	90.38	23.65	57.74	176.12
EV/EBIT Ratio	5.62	6.46	-	34.71	92.64	590.89
EV/FCF Ratio	5.52	6.09	43.26	33.92	144.35	120.31
Debt / Equity Ratio	0.00	0.00	0.01	0.37	0.33	0.42
Debt / EBITDA Ratio	0.01	0.01	0.18	4.14	9.20	24.49
Debt / FCF Ratio	0.01	0.01	0.10	6.05	23.85	18.97
Asset Turnover	0.46	0.46	0.14	0.13	0.09	0.10
Inventory Turnover	3.27	3.27	3.06	3.29	3.50	4.66
Quick Ratio	3.39	3.39	3.22	1.45	11.77	11.06
Current Ratio	4.19	4.19	4.07	1.57	12.99	11.60
Return on Equity (ROE)	29.31%	29.31%	-2.47%	3.58%	4.75%	-1.99%
Return on Assets (ROA)	15.87%	15.87%	-0.18%	2.24%	0.99%	0.19%
Return on Capital (ROIC)	20.39%	20.39%	-0.22%	2.66%	1.11%	0.20%
Return on Capital Employed (ROCE)	24.90%	24.90%	-	5.00%	1.40%	0.30%
Earnings Yield	13.17%	12.23%	-1.23%	1.70%	2.03%	-0.70%
FCF Yield	15.61%	14.49%	2.20%	2.83%	0.67%	0.78%
Dividend Yield	3.02%	3.13%	3.86%	1.83%	1.67%	-
Payout Ratio	24.09%	24.09%	-	90.61%	-	-
Buyback Yield / Dilution	-1.94%	-1.94%	1.95%	2.83%	-16.81%	1.11%
Total Shareholder Return	1.08%	1.19%	5.81%	4.66%	-15.15%	1.11%

Updated Jul 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.